Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001231919-25-000641·Frazier Life Sciences Public Fund, L.P.
Schedule 13G ownership disclosure
Vor BioPharma Inc
Common Stock, $0.0001 par value per share · CUSIP: 929033207
Event date: 2025-12-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 2,258,001.00 · Class: 5.8%
- FHMLSP, L.P.
Shares: 2,258,001.00 · Class: 5.8%
- FHMLSP, L.L.C.
Shares: 2,258,001.00 · Class: 5.8%
- Frazier Life Sciences XI, L.P.
Shares: 21,114.00 · Class: 0.1%
- FHMLS XI, L.P.
Shares: 21,114.00 · Class: 0.1%
- FHMLS XI, L.L.C.
Shares: 21,114.00 · Class: 0.1%
- Frazier Life Sciences XII, L.P.
Shares: 264,824.00 · Class: 0.7%
- FHMLS XII, L.P.
Shares: 264,824.00 · Class: 0.7%
- FHMLS XII, L.L.C.
Shares: 264,824.00 · Class: 0.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001231919-25-000641
- Form type
- SCHEDULE 13G
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Dec 19, 2025
- Reporting period
- Dec 18, 2025
- Description
- Schedule 13G beneficial ownership